Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2018 | 01-2018 | 10-2017 | 07-2017 | 04-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,060 | 1,508 | 2,682 | 4,278 | 3,464 |
| TOTAL | $1,284 | $1,596 | $2,786 | $4,396 | $3,539 |
| Non-Current Assets | |||||
| Investments And Advances | 1,572 | 1,572 | 1,572 | 1,572 | 1,572 |
| Intangibles | 3,549 | 3,549 | 3,549 | 3,549 | 3,549 |
| Other Non-Current Assets | 7 | 7 | 7 | 7 | 7 |
| TOTAL | $5,129 | $5,129 | $5,129 | $5,129 | $5,129 |
| Total Assets | $6,413 | $6,725 | $7,915 | $9,525 | $8,668 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 353 | 306 | 311 | 628 | 366 |
| Accrued Expenses | 292 | 282 | 256 | 238 | 215 |
| Other current liabilities | N/A | 300 | N/A | N/A | N/A |
| TOTAL | $644 | $887 | $567 | $866 | $580 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $644 | $887 | $567 | $866 | $580 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 729 | 709 | 682 | 681 | 681 |
| Common Shares | 101 | 98 | 97 | 97 | 91 |
| Retained earnings | -95,964 | -94,669 | -92,638 | -90,824 | -89,135 |
| Other shareholders' equity | -5 | -1 | 0 | 0 | 2 |
| TOTAL | $5,769 | $5,838 | $7,348 | $8,659 | $8,087 |
| Total Liabilities And Equity | $6,413 | $6,725 | $7,915 | $9,525 | $8,667 |